Previous Article
Molecular and Cellular Biology, November 2003, p. 7926-7936, Vol. 23, No. 21
0270-7306/03/$08.00+0 DOI: 10.1128/MCB.23.21.7926-7936.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
BARD1 Participates with BRCA1 in Homology-Directed Repair of Chromosome Breaks
Ulrica K. Westermark,1 Marsha Reyngold,2 Adam B. Olshen,3 Richard Baer,2 Maria Jasin,1* and Mary Ellen Moynahan4*
Department of Medicine,4
Cell Biology Program,1
Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021,3
Institute for Cancer Genetics, College of Physicians and Surgeons, Columbia University, New York, New York 100322
Received 19 June 2003/
Returned for modification 14 July 2003/
Accepted 24 July 2003
The BRCA1 tumor suppressor has been implicated in the maintenance of chromosomal stability through homology-directed repair of DNA double-strand breaks. Much of the BRCA1 in cells forms a heterodimeric complex with a structurally related protein BARD1. We report that expression of truncated mouse or human BARD1 peptides capable of interacting with Brca1 results in a homologous-repair deficiency. Repair is mildly reduced in Brca1 wild-type cells and severely reduced in cells that harbor a Brca1 splice product deleted for exon 11. Nuclear localization of the Brca1 or BARD1 peptides is not compromised, implying that the repair deficiency is caused by a more direct effect on repair. The tumor suppressor activity of BRCA1 may require the participation of BARD1 to maintain chromosome integrity through the homologous-repair pathway.
* Corresponding authors. Mailing address for Mary Ellen Moynahan: Department of Medicine, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021. Phone: (212) 639-2158. Fax: (212) 717-3317. E-mail:
moynaham{at}mskcc.org. Mailing address for Maria Jasin: Cell Biology Program, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021. Phone: (212) 639-7438. Fax: (212) 717-3317. E-mail:
m-jasin{at}ski.mskcc.org.
Molecular and Cellular Biology, November 2003, p. 7926-7936, Vol. 23, No. 21
0022-538X/03/$08.00+0 DOI: 10.1128/MCB.23.21.7926-7936.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Ryser, S., Dizin, E., Jefford, C. E., Delaval, B., Gagos, S., Christodoulidou, A., Krause, K.-H., Birnbaum, D., Irminger-Finger, I.
(2009). Distinct Roles of BARD1 Isoforms in Mitosis: Full-Length BARD1 Mediates Aurora B Degradation, Cancer-Associated BARD1{beta} Scaffolds Aurora B and BRCA2. Cancer Res.
69: 1125-1134
[Abstract]
[Full Text]
-
Reid, L. J., Shakya, R., Modi, A. P., Lokshin, M., Cheng, J.-T., Jasin, M., Baer, R., Ludwig, T.
(2008). E3 ligase activity of BRCA1 is not essential for mammalian cell viability or homology-directed repair of double-strand DNA breaks. Proc. Natl. Acad. Sci. USA
105: 20876-20881
[Abstract]
[Full Text]
-
Shakya, R., Szabolcs, M., McCarthy, E., Ospina, E., Basso, K., Nandula, S., Murty, V., Baer, R., Ludwig, T.
(2008). The basal-like mammary carcinomas induced by Brca1 or Bard1 inactivation implicate the BRCA1/BARD1 heterodimer in tumor suppression. Proc. Natl. Acad. Sci. USA
105: 7040-7045
[Abstract]
[Full Text]
-
Laufer, M., Nandula, S. V., Modi, A. P., Wang, S., Jasin, M., Murty, V. V. V. S., Ludwig, T., Baer, R.
(2007). Structural Requirements for the BARD1 Tumor Suppressor in Chromosomal Stability and Homology-directed DNA Repair. J. Biol. Chem.
282: 34325-34333
[Abstract]
[Full Text]
-
Tembe, V., Henderson, B. R.
(2007). BARD1 Translocation to Mitochondria Correlates with Bax Oligomerization, Loss of Mitochondrial Membrane Potential, and Apoptosis. J. Biol. Chem.
282: 20513-20522
[Abstract]
[Full Text]
-
Karppinen, S-M, Barkardottir, R B, Backenhorn, K, Sydenham, T, Syrjakoski, K, Schleutker, J, Ikonen, T, Pylkas, K, Rapakko, K, Erkko, H, Johannesdottir, G, Gerdes, A-M, Thomassen, M, Agnarsson, B A, Grip, M, Kallioniemi, A, Kere, J, Aaltonen, L A, Arason, A, Moller, P, Kruse, T A, Borg, A, Winqvist, R
(2006). Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies. J. Med. Genet.
43: 856-862
[Abstract]
[Full Text]
-
Kim, H.-S., Li, H., Cevher, M., Parmelee, A., Fonseca, D., Kleiman, F. E., Lee, S. B.
(2006). DNA Damage-Induced BARD1 Phosphorylation Is Critical for the Inhibition of Messenger RNA Processing by BRCA1/BARD1 Complex.. Cancer Res.
66: 4561-4565
[Abstract]
[Full Text]
-
Simons, A. M., Horwitz, A. A., Starita, L. M., Griffin, K., Williams, R. S., Glover, J.N. M., Parvin, J. D.
(2006). BRCA1 DNA-Binding Activity Is Stimulated by BARD1. Cancer Res.
66: 2012-2018
[Abstract]
[Full Text]
-
Choudhury, A. D., Xu, H., Modi, A. P., Zhang, W., Ludwig, T., Baer, R.
(2005). Hyperphosphorylation of the BARD1 Tumor Suppressor in Mitotic Cells. J. Biol. Chem.
280: 24669-24679
[Abstract]
[Full Text]
-
Schuchner, S., Tembe, V., Rodriguez, J. A., Henderson, B. R.
(2005). Nuclear Targeting and Cell Cycle Regulatory Function of Human BARD1. J. Biol. Chem.
280: 8855-8861
[Abstract]
[Full Text]
-
Nakanishi, K., Yang, Y.-G., Pierce, A. J., Taniguchi, T., Digweed, M., D'Andrea, A. D., Wang, Z.-Q., Jasin, M.
(2005). Human Fanconi anemia monoubiquitination pathway promotes homologous DNA repair. Proc. Natl. Acad. Sci. USA
102: 1110-1115
[Abstract]
[Full Text]
-
Stark, J. M., Pierce, A. J., Oh, J., Pastink, A., Jasin, M.
(2004). Genetic Steps of Mammalian Homologous Repair with Distinct Mutagenic Consequences. Mol. Cell. Biol.
24: 9305-9316
[Abstract]
[Full Text]
-
Karppinen, S-M, Heikkinen, K, Rapakko, K, Winqvist, R
(2004). Mutation screening of the BARD1 gene: evidence for involvement of the Cys557Ser allele in hereditary susceptibility to breast cancer. J. Med. Genet.
41: e114-e114
[Full Text]
-
Choudhury, A. D., Xu, H., Baer, R.
(2004). Ubiquitination and Proteasomal Degradation of the BRCA1 Tumor Suppressor Is Regulated during Cell Cycle Progression. J. Biol. Chem.
279: 33909-33918
[Abstract]
[Full Text]